<?xml version="1.0" encoding="UTF-8"?>
<p>The title compound was prepared from the reaction of compound 
 <bold>15c</bold> (0.60 g, 2 mmol) with 4-methoxyphenyl isocyanate (0.33 g, 2.2 mmol) according to the general procedure A. Compound 
 <bold>17c</bold> was obtained as white amorphous solid product, m.p. 245–7 °C, yield 69%. IRʋ
 <sub>max</sub>/cm
 <sup>−1</sup> 3294, 3163 (NHs), 3088 (aromatic C–H), 2212 (CN), 1663 (COs), 1631, 1605 (C = C, C = N), 1489, 1403, 1322, 1210 (C–N, C–O), 790 (C–Cl). 
 <sup>1</sup>H-NMR (CDCl
 <sub>3</sub>, 500 MHz, ppm) 
 <italic>δ</italic>: 
 <italic>δ</italic> 2.56–2.50 (m, 2H, pyrrolizine C
 <underline>H
  <sub>2</sub>
 </underline>-2), 2.98 (t, 2H, 
 <italic>J</italic> = 7.5 Hz, pyrrolizine C
 <underline>H
  <sub>2</sub>
 </underline>-1), 3.80 (s, 3H, 4-OC
 <underline>H
  <sub>3</sub>
 </underline>), 4.39 (t, 2H, 
 <italic>J</italic> = 7.2 Hz, pyrrolizine C
 <underline>H
  <sub>2</sub>
 </underline>-3), 6.20 (s, 1H, NH), 6.88 (d, 2H, 
 <italic>J</italic> = 8,9 Hz, MeO-Ph CH-3 + CH-5), 7.31–7.22 (m, 5H, NH, Cl-Ph CH-3 + CH-5, MeO-Ph CH-2 + CH-6 + pyrrolizine-NHCO), 7.53 (d, 2H, 
 <italic>J</italic> -= 8.8 Hz, Cl-Ph CH-2 + CH-6), 9.62 (s, 1H, Cl-Ph-NH). 
 <sup>13 </sup>C-NMR (CDCl
 <sub>3</sub>, 125 MHz, 
 <italic>δ</italic> ppm): 
 <italic>δ</italic> 24.9 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-2), 25.7 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-1), 49.7 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-3), 55.7 (O
 <underline>C</underline>H
 <sub>3</sub>), 84.6 (pyrrolizine C-7), 114.6 (MeO-Ph 
 <underline>C</underline>H-3+
 <underline>C</underline>H-5), 115.6 (CN), 117.0 (MeO-Ph C-1), 120.4 (MeO-Ph CH-2 + CH-6), 120.9 (Cl-Ph CH-2 + CH-6), 129.1 (4-Cl-Ph C-4), 129.8 (4-Cl-Ph 
 <underline>C</underline>H-3+
 <underline>C</underline>H-5), 131.6 (pyrrolizine C-5), 133.0 (pyrrolizine C-7a), 136.7 (pyrrolizine C-6), 146.6 (4-Cl-Ph), 153.6 (NHCONH), 155.9 (MeO-Ph 
 <underline>C</underline>-4), 159.0 (4-Cl-Ph-NH
 <underline>C</underline>O). DEPT C
 <sup>135</sup> (CDCl
 <sub>3</sub>, 125 MHz, 
 <italic>δ</italic> ppm): 
 <italic>δ</italic> 24.9 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-2), 25.7 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-1), 49.7 (pyrrolizine 
 <underline>C</underline>H
 <sub>2</sub>-3), 55.7 (O
 <underline>C</underline>H
 <sub>3</sub>), 114.6 (MeO-Ph 
 <underline>C</underline>H-3+
 <underline>C</underline>H-5), 120.4 (MeO-Ph CH-2 + CH-6), 120.9 (Cl-Ph CH-2 + CH-6), 129.8 (4-Cl-Ph 
 <underline>C</underline>H-3+
 <underline>C</underline>H-5). MS (EI): 
 <italic>m</italic>/
 <italic>z</italic> (%) 451 ([M + 2]
 <sup>+</sup>, 4), 450 ([M + 1]
 <sup>+</sup>, 5), 447 ([M-2]
 <sup>+</sup>, 2), 445 (4), 434 (5), 406 (3), 395 (8), 368 (10), 352 (6), 301 (6), 273 (44), 272 (100), 271 (14), 248 (3), 134 (6), 123 (62), 122 (7), 108 (78), 95 (17), 91 (4), 77 (20). Anal. Calcd. for C
 <sub>23</sub>H
 <sub>20</sub>ClN
 <sub>5</sub>O
 <sub>3</sub> (449.89): C, 61.40; H, 4.48; N, 15.57. Found: C, 60.96; H, 4.81; N, 15.78.
</p>
